Chromosomal abnormalities are responsible for a great deal of embryo wastage, which is reflected, at least partially, in decreased implantation and increased miscarriage in older women. To address this problem the transfer of only chromosomally normal embryos previously selected by preimplantation genetic diagnosis (PGD) has been proposed. We designed a multi-centre in-vitro fertilization (IVF) study to compare controls and a test group that underwent embryo biopsy and PGD for aneuploidy. Patients were matched retrospectively, but blindly, for average maternal age, number of previous IVF cycles, duration of stimulation, oestradiol concentrations on day ⍣1, and average mature follicles. All these parameters were similar in test and control groups. Only embryos classified as normal for those chromosomes were transferred after PGD. The results showed that the rates of fetal heart beat (FHB)/embryo transferred between the control and test groups were similar. However, spontaneous abortions, measured as FHB aborted/FHB detected, decreased after PGD (P < 0.05), and ongoing pregnancies and delivered babies increased (P < 0.05) in the PGD group of patients. Two conclusions were obtained: (i) PGD of aneuploidy reduced embryo loss after implantation; (ii) implantation rates were not significantly improved, but the proportion of ongoing and delivered babies was increased. Key words: in-vitro fertilization/preimplantation genetic diagnosis/trisomy 21, 18, 13, 16 *Some of the data in this paper were presented as an abstract in the 54th Annual Meeting of The American Society of Reproductive Medicine (San Francisco, CA, USA, 1998), where it was designated the Prize Paper of the Society for Assisted Reproductive Technology.
Introduction
The causes of the decline in implantation observed with increasing maternal age are still debated. The high implantation rate in women Ͼ40 years old observed after transfer of embryos from younger women strongly suggests that their ability to become pregnant is largely unaffected, whereas their oocyte quality is compromised (Navot et al., 1994) . Altered oocyte metabolism such as ATP production (Van Blerkom, 1995) and excessive deposition of zona pellucida glycoproteins (Garside et al., 1997) have been associated with advanced maternal age. More important, genetic analysis of aborti and live offspring have shown that older women are at a higher risk of conceiving trisomic fetuses and that most of these are maternal in origin (Hassold and Chiu, 1985; Warburton et al., 1986; Antonorakis et al., 1991; Fisher et al., 1995) . Similarly, a significant increase in aneuploidy with maternal age was found in both unfertilized oocytes and cleavage-stage embryos (Munné et al., 1995a,b) . The rate of chromosomal abnormalities in embryos is considerably higher than the one reported in spontaneous abortions, suggesting that a considerable proportion of chromosomally abnormal embryos are eliminated before any prenatal diagnosis. Such loss may partly account for the decline in implantation in older women. For instance, the rate of embryonic monosomy is similar to the one for trisomy, whereas, with the exception of monosomy 21 (1/1000 karyotyped abortions), autosomal monosomies are normally undetected in pregnancy (Munné et al., 1995a) . Other evidence comes from the observations that blastocyst formation declines with maternal age in women Ͼ30 years, and that more embryos arrest at the morula stage, being possibly monosomic or developmentally affected (Janny and Ménézo 1996) .
Because of the association between aneuploidy and implantation, it was postulated that selection of chromosomally normal embryos could reverse this trend (Munné et al., 1993) . However, while some research groups felt that this was possible and desirable (Verlinsky and Kuliev, 1996: Gianaroli et al., 1997) others doubted its value or feasibility (Egozcue, 1996; Reubinoff and Sushan, 1996) . Currently, removal of aneuploid embryos can only be done through PGD, after either polar body or blastomere analysis. Fluorescence in-situ hybridization (FISH) allows chromosome enumeration on interphase cell nuclei, i.e. without the need for culturing cells or preparing metaphase spreads. FISH has been applied to preimplantation genetic diagnosis (PGD) of common aneuploidies (at least XY, 13, 18, 21), testing either human blastomeres from cleavage-stage embryos or oocyte polar bodies (Munné et al., 1993 (Munné et al., , 1995a (Munné et al., ,b, 1998a Manor et al., 1996; Verlinsky et al., 1995 Verlinsky et al., , 1996b Gianaroli et al., 1997) . More than 500 cycles have been performed using this technique, resulting in Ͼ100 chromosomally normal babies. However, an increase in implantation rate or a decrease in abnormal offspring has not been demonstrated, either for lack of data or appropriate controls. Here we present the first study including carefully matched retrospective controls to analyse whether PGD of aneuploidy has any effect on implantation rates, spontaneous abortions, and live births.
Materials and methods

Clinical cases
PGD was performed in three centres. Written consent was obtained from patients in accordance with each internal review board protocol. Inclusion of patients followed these criteria: maternal age was ജ35 years; at least one embryo was replaced; pregnancy information was available at least up to the 20th week of pregnancy; and all replaced embryos were classified as chromosomally normal.
Patient matching
Patients 35 years or older undergoing in-vitro fertilization (IVF) treatment at the three centres participating in this study were offered PGD of aneuploidy. Randomization was initially offered but, because there was no data supporting a beneficial effect of PGD of aneuploidy, few patients agreed to the study and those committed to it rejected randomization. Therefore, the study was planned as a retrospective study where controls were matched to test patients blindly or previous pregnancy outcome was known. PGD cases for centres 2 and 3 were matched, as far as was possible, on the following variables which are listed in order of matching priority: maternal age (Ϯ1 year); concentration of oestradiol (with a difference between control and test of Ϯ20%); month of retrieval; duration of stimulation; and number of mature follicles. The rationale for matching them according to these factors, in addition to maternal age, was to avoid changes in laboratory performance and to control for ovarian reserve and response (Scott and Hofmann, 1995) . Patients from centre 1 were also matched according to the number of previous IVF attempts. This extra condition is included because in that centre implantation significantly decreases between the first and second attempt. This phenomenon was not observed in many other centres (see review Meldrum et al., 1998b) The controls also fulfilled the requirements that at least one embryo was replaced and that pregnancy information was available at least up to the 20th week of pregnancy.
Biopsy, fixation and fish procedure During day 3 of development, one or two cells per embryo were biopsied, and the embryos returned to culture as described elsewhere (Grifo, 1992) . All of the embryos were at the 4-12-cell stage of development at the time of biopsy. Most embryos classified as normal after PGD were transferred to the uterus on the same day of analysis. All blastomeres were fixed individually following our protocol .
The present study has taken 2 years, during which fluorescence insitu hybridization (FISH) protocols for PGD of aneuploidy have evolved considerably. PGD cases included in this study were therefore performed using the protocols available at the time. Some cases used probes for simultaneous detection of chromosomes X, Y, 18 and the shared alpha-satellite region of chromosomes 13 and 21 (Munné et al., 1993) (n ϭ 14). Later on, cases used specific probes for X, Y, 13, 18 2192 and 21 (n ϭ 22). Later still, a probe for chromosome 16 was added to the previous mixture (Munné et al., 1998a) and used in a proportion of the cases (n ϭ 50). And finally, a small fraction of cases (n ϭ 31) benefited from having the biopsied cells analysed with the X, Y, 13, 16, 18, and 21 probe mixture (Munné et al., 1998b) , and re-analysed with a second probe mixture specific for chromosomes 14, 15 and 22. Thereby all the cases had their biopsied cells analysed for the trisomies with potential of arriving to term (X, Y, 13, 18, 21) , and some for trisomies commonly found in spontaneous abortions, but which do not survive to term (14, 15, 16, 22) . The protocols for these probe sets have been previously published (Munné et al., 1993 (Munné et al., , 1998a and a few of the cases here reported were also included in previous manuscripts (Munné et al., , 1998a .
The FISH error rate has already been evaluated in previous studies of probes for X, Y, 18, 13/21 (7%) (Munné et al., 1993) ; X, Y, 13, 18, 21 (13%) ; X, Y, 13, 16, 18, 21 (9%) (Munné et al., 1998a); and X, Y, 13, 16, 18, 21, 14, 15, 22 (15%) (Munné et al., 1998b) . The scoring criteria (described in were applied in any cases that used at least probes specific for X, Y, 13, 18 and 21 chromosomes.
Statistical analysis
The patients in the two treatment groups were matched, primarily by age, but also to a lesser extent by oestradiol and cycles of IVF. This was to avoid any potential bias caused by these variables.
The data were analysed in the following way. For each patient the statistic of interest (say FHB/transfer) was calculated, and from that the mean values and standard errors were calculated. Thus the 'error' reflects inter-patient variation. This is a more appropriate way to analyse the data than by counting embryos as units. Therefore, following the example of the variable 'FHB/transfer', the mean for that variable would not be the sum of all FHB divided by the total number of embryos transferred. The variables of interest were generally proportions based on very small frequencies, so that great care was required in the statistical analysis.
Since the variables of interest were proportions, the main method of analysis was logistic regression. The variables contributing to the proportions of interest (for example number of FHB/transfer) were entered into the GLM (generalized linear modelling) analysis, which then tested for systematic differences caused by treatment and centre. Maternal age was also included as a covariate, but, because of the matching process described above, this had minimal impact. The analysis generated estimated mean values and standard errors for the various sub-groups, these figures being quoted in the tables. The statistical tests were carried out within the algorithm, and the findings are also quoted in the tables. The algorithm used to carry out the calculations was Genstat (1988) .
Results
Fitness of controls
Women (n ϭ 117) undergoing PGD for aneuploidy were matched with controls (n ϭ 117). The parameters for which the cases were matched and the outcome for each of the 234 patients are available from the authors (see Appendix). The matching procedure was successful in that the relevant mean values for the two treatment groups were fairly similar, as may be seen below. Maternal age in both test and control groups averaged 38.5 (mean Ϯ 0.23 SD). The duration of stimulation averaged 11.7 (mean Ϯ 3.2 SD) days in test and Values are means Ϯ SD. FHB ϭ fetal heart beat.
11.1 (mean Ϯ 3.2 SD) days in controls. The average mature follicles numbered 12.6 (mean Ϯ 6.7 SD) (test) and 12.4 (mean Ϯ 5.8 SD) (controls). In addition, for centre 1, the average number of repeated IVF cycles was 1.9 (mean Ϯ 1.2 SD) cycles (test) and 1.8 (mean Ϯ 1.0 SD) cycles (controls). Oestradiol concentrations on day Ϯ1 were measured with different systems in each centre, therefore an average is not given. Nevertheless, there was no statistical evidence of a systematic difference between test and controls regarding oestradiol or any other parameter.
Pregnancy outcome
The overall results and statistical analysis are shown in Table I . Implantation rates, as FHB/embryo, were slightly higher in the PGD group (17.8%) but not statistically different from the control group (13.7%). However, spontaneous abortions (lost FHB/ FHB detected) decreased 2.5-fold after PGD (P Ͻ 0.05), from 23% in control to 9% in the test group. The slight increase in implantation and the significant decrease in spontaneous abortions resulted in a significant increase (P Ͻ 0.05) in ongoing and delivered babies, from 10.5% (43/408) in controls to 16.1% (57/354) in the PGD group. When the experimental data were summarized as the number of patients becoming pregnant, or miscarrying, the trends were similar to those observed in Table  I , although the findings were not statistically significant. It would appear therefore that the additional information contained in 2193 variables such as 'number of transfers' was necessary in order to highlight the treatment differences. Also the results derived from the rather complex GLM (general linear modelling) method of Table I could often be replicated by a more simple approach. Thus if the ratio (ongoing/transfer) was calculated for each patient, the mean Ϯ SD for the PGD group was 0.157 Ϯ 0.024, and for the controls was 0.107 Ϯ 0.021, values very similar to those quoted in Table I . Furthermore, working with pairs of matched patients, we found that in 66 the same ratio was obtained, in 32 pairs the PGD ratio was greater than the control ratio, and in 19 pairs the control ratio was greater than the experimental group ratio. Therefore, of the 51 pairs where there was a non-zero difference in the ratios, the PGD ratio was the higher in 32 of those pairs. The departure from the expected value under the null hypothesis (25.5) was just significant at the 5% level, thus supporting the finding in Table I . Thus by adopting a completely different, non-parametric approach of counting differences, we obtained precisely the same result as the GLM analysis used to produce Table I.  Table II shows the results obtained when calculated per centre. Because the numbers of cases were often quite small, it was not possible to employ a matched procedure, and these results are derived from an unpaired investigation. Although the trends were similar at the three centres and consistent with the overall results, the number of cases was not sufficient to provide a conclusive statistical finding.
When the data were analyse by probe combination used we found a higher decrease in spontaneous abortions when using XY, 13, 14, 15, 16, 18, 21, 22 probe combination (from 29% in controls to 4% in test group) than when other probes were used (20% in controls to 12.5% in test group). Implantation rates appeared to increase only when the XY, 13, 14, 15, 16, 18, 21, 22 probe combination was used, increasing from 18% in controls to 31% in the test group. However, due to the small sample size, these differences were not statistically different.
Analysis during prenatal diagnosis and after birth showed no abnormalities in the test group for the chromosomes assessed. However, a spontaneous abortion was shown to be trisomy 21. The cells belonging to the transferred embryos of the case resulting in trisomy 21 were re-hybridized with a probe for chromosome 21 (already described in a previous study) (Munné et al., 1998b) and the same normal result was obtained.
Discussion
Preimplantation genetic diagnosis of aneuploidy using probes for four to eight chromosome pairs was performed in 117 couples of advanced maternal age. Their pregnancy results were then compared blindly and retrospectively to 117 controls matched by age, days of hormonal stimulation, oestradiol concentrations, and, for centre 1, repeated IVF cycles. The results indicated an increase in implantation rates, although not statistically significant, from 14% in the test group to 18% in the PGD group. Spontaneous abortions decreased 2.5-fold, from 23% in controls to 9% in the PGD group, which, combined with the slight increase in implantation rate in the PGD group, produced a significant increase in ongoing and delivered babies from 11% in controls to 16% in the PGD group.
From the present results, it can be postulated that aneuploidy determination prior to embryo transfer may reduce the incidence of miscarriage, and increase the rate of delivery. Because the chromosomes analysed in this study are involved in at least threequarters of chromosomally abnormal miscarriages (SchmidtSarosi et al., 1998) , a reduction in pregnancy loss should be expected, and emphasizes the accuracy of the proposed hypothesis. It is important to consider the conditions under which these results were obtained, emphasizing the need for further, more advanced studies. The results were evaluated retrospectively and obtained in three different centres, during a 3 year period. During this period, conditions of assisted reproduction changed, most notably in the use of follicular stimulation protocols, but also because other probes became available. An increase in ongoing pregnancies and live births was most notably due to a reduction of the occurrence of miscarriage.
In most IVF centres there is a reduction of~30-50% in implantation rate from patients 25-34 to 35-42 years old. If such decrease were solely produced by chromosome abnormalities, we would expect an increase in implantation after PGD of a similar magnitude, provided sufficient number of oocytes were available, which is not the case. The low PGD effect on implantation can be attributed to at least three factors. One could be that the chromosomes chosen for this test are those producing abnormalities compatible with further development. For instance, trisomy 1 is found in cleavage stage embryos but never detected in spontaneous abortions (Watt et al., 1987; Simpson 1990; Delhanty et al., 1997; Laverge et al., 1997) , and other chromosomes, such as 17, seldom found in spontaneous abortions, are quite common in cleavage-stage embryos (Simpson, 1990; Bahçe et al., 1999) . The importance of the probes used is also evident when comparing PGD cases performed with different probe mixtures, with the one used to test eight chromosomes producing the highest implantation rate improvement and the highest reduction in spontaneous abortions.
A second factor would be that the working hypothesis is incorrect, namely, in opposition to previously held ideas, chromosomally abnormal embryos may in fact often implant, many of them dying shortly afterwards and being detected as empty sacs. This would also imply that embryos of women of advanced maternal age may be less likely to implant because of nonchromosomal causes.
The third factor affecting implantation might be the embryo biopsy procedure. Although a previous study on embryo biopsy did not show a negative effect on embryo development to blastocyst (Hardy et al., 1990) , embryo transfer effects, if any, were not assessed. Moreover, the embryos studied were from donors and not from older patients or those with a poor prognosis. Evidence of embryo damage during transfer of zona-drilled embryos comes from assisted hatching studies. For instance, assisted hatching has been demonstrated to increase implantation rates (Cohen et al., 1990) , but its potential is related to the diameter of the opening in the zona. Openings of 40-60 µm diameter commonly used for biopsy, instead of the recommended 20-30 µm for assisted hatching, might eliminate any beneficial effect (B.Schoolcraft and T.Schlenker, personal communication), and cause embryo damage immediately after the procedure or during and after embryo transfer. Preliminary data from one of the centres reporting in this study, compared two embryologists performing embryo biopsies, one with zona openings 40-50 µm in diameter and the other 30-40 µm. The first obtained a 13% (22/166) implantation rate per embryo transferred compared to 21% (16/76) of the second embryologist. Although the differences were not significant, they point again to a very serious detrimental effect of large zona openings. Another effect of embryo biopsy could be the toxicity of acidified Tyrode's solution on the adjacent blastomeres, although the appearance of effective laser devices could make its use obsolete (Montag et al., 1998) . Other negative effects of embryo biopsy may be that it interferes with cell allocation and positioning during compaction and blastulation (Edwards and Beard, 1998) . However, embryos with 15% fragments and seven cells on day 3, have the same implantation rate as 8-cell embryos when the fragments have been removed (Alikani et al., 1999) , and these embryos could be compared to biopsied embryos in which one cell has been removed. Similarly, linear tracing experiments have demonstrated that any cell of an 8-cell embryo could produce ICM (Mottla et al., 1995) . A more clear negative effect of embryo biopsy could be the interference with compaction. For instance, data from centre 1 indicates that there is a 4% decrease in embryo implantation when the biopsy is performed 70 h or later after embryo retrieval compared to when it is performed 67 h or earlier. Clearly, more research is needed on the effect of embryo biopsy on implantation, when beneficial effects such as PGD are excluded.
The potential hazards of embryo biopsy could be avoided by using polar body instead of blastomere biopsy (Verlinsky et al., 1995 (Verlinsky et al., , 1996 . Polar body biopsy can be performed by mechanical or laser techniques and does not interfere with cell allocation. The hole in the zona is on average 10-20 µm, about the size recommended for AHA. If the polar body approach is taken, the issue of which probes to use might be solved using spectral imaging techniques (Schröck et al., 1996) to karyotype all 23 chromosomes of the polar body as already demonstrated (Márquez et al., 1998) . Although most aneuploidies are maternal in origin, polar body analysis would not detect other abnormalities such as polyploidy, haploidy and mosaicism involving most or all cells and accounting for at least 19% of embryonic chromosome abnormalities (Munné et al., 1995) .
In conclusion, the present study demonstrates that PGD of aneuploidy can positively affect the outcome of embryos by reducing embryo wastage and increasing implantation rates. As PGD of aneuploidy now stands, patients of advanced maternal age undergoing IVF can benefit from this technique by avoiding the trauma of losing greatly desired pregnancies and giving themselves a greater chance of having a baby. Because the procedure appears beneficial, further research can continue in order to elucidate the causes behind the disappointing effects on implantation. We are currently investigating the use of other probes, spectral imaging, laser embryo biopsy and polar body biopsy in a randomized study to improve the procedure, hopefully to bring implantation rates in those women in line with the rates found in younger patients. Simpson, J.L. (1990) 1  40  8  4712  19  25  2  1  4  0  0  0  0  0  9  1  42  8  5596  14  17  2  1  4  0  0  0  0  0  10  1  40  11  1835  8  11  2  1  5  0  0  0  0  0  11  1  39  10  3062  19  18  1  1  5  1  0  1  0  1  12  1  39  11  4852  20  27  2  1  5  1  0  1  0  1  13  3  40  9  3108  27  1  5  0  0  0  0  0  14  3  39  12  1657  7  1  4  1  0  1  0  1  15  1  42  9  3693  11  22  2  2  6  0  0  0  0  0  16  1  39  10  2864  15  33  2  2  5  1  0  1  1  0  17  1  35  12  1550  5  3  1  2  3  2  0  2  0  2  18  1  43  9  2629  15  24  1  2  4  0  0  0  0  0  19  1  35  11  1992  10  19  4  2  4  0  0  0  0  0  20  1  42  7  3358  15  12  2  2  6  0  0  0  0  0  21  1  41  10  2967  21  31  1  2  2  0  0  0  0  0  22  1  35  10  4395  17  28  4  2  4  0  0  0  0  0  23  1  40  11  1684  12  19  1  2  3  1  0  1  0  1  24  1  35  13  3269  14  12  2  2  4  0  0  0  0  0  25  1  36  11  1568  6  5  1  2  3  1  0  1  0  1  26  3  36  12  1127  7  2  1  0  0  0  0  0  27  3  40  11  2128  4  2  1  0  0  0  0  0  28  3  42  12  2616  13  2  2  0  0  0  0  0  29  1  38  9  2994  26  25  1  2  5  1  0  1  0  1  30  2  39  18  1970  5  2  3  2  0  2  0  2  31  2  37  16  2331  7  2  3  2  1  1  0  1  32  2  39  18  1820  7  2  1  0  0  0  0  0  33  2  41  19  1295  5  2  5  1  0  1  0  1  34  2  35  15  2183  6  2  3  0  0  0  0  0  35  3  36  11  3286  18  2  3  1  0  1  0  1  36  3  41  12  2312  12  2  4  0  0  0  0  0  37  2  36  16  3687  13  3  3  0  0  0  0  0  38  2  36  15  2053  8  3  2  0  0  0  0  0  39  2  37  14  2677  7  3  4  0  0  0  0  0  40  2  38  15  790  5  3  3  2  0  2  0  2  41  2  38  17  861  5  3  3  0  0  0  0  0  42  2  36  17  2847  7  3  1  0  0  0  0  0  43  2  38  13  4752  9  3  2  0  0  0  0  0  44  3  39  11  2892  10  3  2  0  0  0  0  0  45  1  41  9  831  11  11  2  3  3  0  0  0  0  0  46  3  39  11  3162  14  3  3  2  0  2  0  2  47  3  42  12  3556  26  3  3  0  0  0  0  0  48  3  37  10  2703  11  3  2  0  0  0  0  0  49  3  39  12  2095  7  3  2  1  0  1  0  1  50  3  39  11  3434  14  3  4  0  0  0  0  0  51  2  38  16  3157  8  3  4  0  0  0  0  0  52  2  35  14  4248  8  3  2  1  0  1  1  0  53  2  35  15  2127  11  3  3  0  0  0  0  0   2196 Verlinsky, Y., Cieslak, J., Ivakhnenko, V. et al. (1996) 
